|
December 15, 2017 0:27 Pfizer announces FDA approval of Xeljanz® (tofacitinib) and Xeljanz® XR active psoriatic arthritis https://www.pfizer.com/news/press-release/press-release-detail/pfizer_announces_fda_approval_of_xeljanz_tofacitinib_and_xeljanz_xr_for_the_treatment_of_active_psoriatic_arthritis 2:48 Medimetriks receives FDA approval for Xepi™ (ozenoxacin) cream, 1%, a novel topical antibiotic for impetigo https://www.prnewswire.com/news-releases/medimetriks-pharmaceuticals-inc-submits-a-new-drug-application-to-fda-for-ozenoxacin-cream-1-a-novel-impetigo-treatment-300290327.html 4:32 Amicus Therapeutics seeks FDA approval for migalastat to treat Fabry disease https://globalgenes.org/raredaily/amicus-therapeutics-seeks-fda-approval-for-migalastat-to-treat-fabry-disease/ 6:05 FDA-approved tests often comparable to lab-developed cancer genetics tests https://www.eurekalert.org/pub_releases/2017-12/bawh-tta121417.php == NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com == First episode of AI in medicine is coming out on Wednesday January 4th, 2018. I will be talking with Dr. Alex Zhavoronkov who is the is the CEO of InSilico Medicine, Inc a company utilizing big data analysis for aging research. https://itunes.apple.com/us/podcast/aimedicines-podcast/id1325232000?mt=2 |